Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis

PHASE3CompletedINTERVENTIONAL
Enrollment

164

Participants

Timeline

Start Date

June 28, 2018

Primary Completion Date

April 11, 2019

Study Completion Date

April 22, 2019

Conditions
Blepharoptosis
Interventions
DRUG

RVL-1201

RVL-1201 ophthalmic solution 0.1%

OTHER

Vehicle ophthalmic solution

Vehicle placebo ophthalmic solution

Trial Locations (36)

11793

South Shore Eye, Wantagh

14618

Rochester Ophthalmological, Rochester

21078

Seidenberg Protzko Eye, Havre de Grace

27262

Cornerstone Eye, High Point

28210

CEENTA, Charlotte

30076

Coastal Research Associates, Roswell

32751

Maitland Vision Center, Maitland

32779

Sabal Eye Care, Longwood

33773

Shettle Eye Research, Largo

34239

Sarasota Retina Institute, Sarasota

34461

West Coast Eye, Lecanto

34615

Hernando Eye Institute, Brooksville

34994

East Florida Eye, Stuart

37205

Nashville vision Associates, Nashville

39564

Mississippi Eye, Ocean Springs

44115

Abrams Eye Center, Cleveland

45243

Apex Eye, Cincinnati

45247

Apex Eye, Cincinnati

45701

Quinn, Foster & Assoc., Athens

63090

Comprehensive Eye Care, Washington

64133

Silverstein Eye, Kansas City

66204

Heart of America Eye, Shawnee Mission

66762

Kennar Eye Care, Pittsburg

78229

R&R Research, San Antonio

78240

Medical Center Ophthalmology Assocs - Keystone Research, San Antonio

78681

Round Rock Eye, Austin

78731

Texan Eye / Keystone, Austin

78734

Lake Travis Eye, Lakeway

85016

Barnet, Dulany Perkins, Phoenix

92056

Pendelton Eye Center, Oceanside

92663

Eye Research Foundation, Newport Beach

92683

Michael Tran, Westminster

92843

Orange County Ophthalmology, Garden Grove

94954

North Bay Eye Associates, Petaluma

941345

North Valley Eye, Mission Hills

06810

Danbury Eye Physicians, Danbury

All Listed Sponsors
lead

RVL Pharmaceuticals, Inc.

INDUSTRY

NCT03565887 - Study of Safety and Efficacy of RVL-1201 in the Treatment of Blepharoptosis | Biotech Hunter | Biotech Hunter